Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle
Author(s) -
Graziella Messina,
Stefano Biressi,
Stefania Monteverde,
Alessandro Magli,
Marco Cassano,
Laura Perani,
Elena Roncaglia,
Enrico Tagliafico,
Linda M. Starnes,
Christine Campbell,
Milena Grossi,
David J. Goldhamer,
Richard M. Gronostajski,
Giulio Cossu
Publication year - 2010
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2010.01.027
Subject(s) - biology , myogenesis , embryonic stem cell , transcription factor , skeletal muscle , microbiology and biotechnology , gene , gene expression , myocyte , fetus , genetics , endocrinology , pregnancy
Skeletal myogenesis, like hematopoiesis, occurs in successive developmental stages that involve different cell populations and expression of different genes. We show here that the transcription factor nuclear factor one X (Nfix), whose expression is activated by Pax7 in fetal muscle, in turn activates the transcription of fetal specific genes such as MCK and beta-enolase while repressing embryonic genes such as slow myosin. In the case of the MCK promoter, Nfix forms a complex with PKC theta that binds, phosphorylates, and activates MEF2A. Premature expression of Nfix activates fetal and suppresses embryonic genes in embryonic muscle, whereas muscle-specific ablation of Nfix prevents fetal and maintains embryonic gene expression in the fetus. Therefore, Nfix acts as a transcriptional switch from embryonic to fetal myogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom